IQVIA France
IQVIA France is the French subsidiary of IQVIA Inc. (NYSE: IQV), providing clinical research services, healthcare data analytics, real-world evidence observatories, and SaaS products (One View, SmartSolve) to pharmaceutical companies, hospitals, pharmacies, and government health agencies across France.
- Company typePublic
- Founded2016
- HeadquartersFrance, France
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
What IQVIA France does
IQVIA France is the French operating subsidiary of IQVIA Inc. (NYSE: IQV), a publicly traded global clinical research and health data analytics company formed in 2016 from the merger of Quintiles Transnational and IMS Health. The French entity has been present in France since 1960 and operates from La Défense with approximately 2,000 experts distributed across the country, collaborating with 400 hospital centers and recruiting roughly 3,000 patients annually into clinical trials.
The company's offering is a hybrid platform-plus-services model. Core software products include One View, a data visualization dashboard for pharma commercial teams covering market shares and competitive dynamics, and SmartSolve, a digital Quality Management System (EQMS) that automates document management, CAPA, deviations, training, and audit workflows. Service offerings center on clinical research support for pharmaceutical sponsors, a portfolio of medical studies and observatories (autoimmune disease, antitumor pharmacotherapy, ambulatory medicine observatory, and short-term targeted studies), a hospital panel data service, and a Partner Physicians Network that enrolls healthcare professionals in longitudinal research. The HEALTHCARE-GRADE AI trademark is positioned across the portfolio as the underlying technology layer.
IQVIA France generates revenue through a mix of project-based professional services in clinical research and medical studies, plus recurring subscription-style data products (One View, SmartSolve). Go-to-market is sales-led direct enterprise engagement targeting five primary segments: pharmaceutical industries (primary), healthcare establishments (primary), pharmacies (primary), government health agencies, and individual healthcare professionals (persona-level). Marketing channels blend content marketing (blog, white papers, case studies), email/newsletter (Constellation platform), and LinkedIn presence, with regional thought leadership content focused on transparency commission activity, medico-economic evaluation, and rare diseases.
IQVIA France firmographics
Firmographics- Name
- IQVIA France
- Legal name
- IQVIA Inc.
- Website
- https://iqvia.fr
- Company type
- Public
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- IQVIA France is the French subsidiary of IQVIA Inc. (NYSE: IQV), providing clinical research services, healthcare data analytics, real-world evidence observatories, and SaaS products (One View, SmartSolve) to pharmaceutical companies, hospitals, pharmacies, and government health agencies across France.
- Ownership category
- akta.pro rank
IQVIA France industry classification
Industry- Product category
- Healthcare Data Analytics and Clinical Research Services
- NAICS
- Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)
- akta.pro secondary industries
- Lab Analytics, Utilization Management & Operational Intelligence (HLACAMAK), Data Analytics & Business Intelligence Services (BPAHALAC), Healthcare & Wellness Personalization (HDAAAGAI)
Keywords
Where IQVIA France is headquartered
LocationHeadquarters
- HQ city
- France
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
IQVIA France business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Clinical Research Services: IQVIA provides clinical research services to pharmaceutical companies and healthcare organizations, including patient recruitment for clinical trials and hospital collaboration
- Health Data and Analytics: Provides data visualization solutions (One View), quality management systems (SmartSolve), and analytical insights to healthcare industry stakeholders
- Medical Studies and Observatories: Medical studies for healthcare professionals including studies on medical visits, liberal medical prescription, autoimmune disease observatories, and anti-tumor pharmacotherapy observatories
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
IQVIA France product offering
Product offeringCore offering
IQVIA France provides clinical research services, health data analytics, and quality management solutions to the French healthcare ecosystem. Its core offerings include patient recruitment for clinical trials (nearly 3,000 patients annually across 400 hospital centers), data visualization platforms such as One View for market performance, the SmartSolve Quality Management System for digitizing quality processes, and a portfolio of medical studies programs serving pharmaceutical companies, healthcare establishments, pharmacies, and government health agencies.
Product overview
IQVIA France operates as a unified platform-plus-modules architecture combining data analytics, quality management, and clinical research services. The core offerings include One View (data visualization dashboard for healthcare market performance), SmartSolve (Quality Management System for automating quality processes), and a portfolio of medical studies programs (IQVIA Études médicales, IQVIA Observatoire de la Médecine de Ville, Panel hospitalier). These products connect healthcare data, information, technologies, and expertise to support pharmaceutical companies, healthcare facilities, pharmacies, government agencies, and payers throughout the patient care journey from diagnosis to care quality and access. Healthcare-grade AI serves as the underlying technology trademark across the portfolio.
Differentiator
Problem solved
Functional benefit
Products and services
- One View One View is a data visualization solution designed for marketing and commercial teams in the healthcare sector. It provides an intuitive, pre-formatted dashboard enabling quick access to market performance metrics including market shares, competitive dynamics, and presence in high-potential points of sale.
- SmartSolve SmartSolve is a Quality Management System (SMQ) that enables digitization of quality processes. The unified platform automates document management (GED), CAPA, deviations, training, OOS, Design Control, audits, non-conformity management, and other quality-related workflows from a single interface.
- IQVIA Études médicales (Medical Studies) Medical studies program connecting healthcare professionals with clinical research. Includes studies on medical promotion visits, liberal medical prescriptions, autoimmune disease observatory, targeted short-term studies, and antitumor pharmacotherapy observatory. Collaborates with 400 hospital centers and enrolls nearly 3,000 patients annually in clinical trials.
- IQVIA Observatoire de la Médecine de Ville City medicine observatory providing insights and monitoring of ambulatory healthcare practices and trends in France.
- Panel hospitalier (Hospital Panel) Hospital panel providing data and analytics on hospital healthcare practices, prescriptions, and market dynamics across French hospital centers.
Quantifiable outcome
- Nearly 3000 patients recruited annually for clinical trials
- +1 more outcomes
Companies that use IQVIA France
Customer profileNamed customers2 records
Segments5 records
Ideal customer profiles4 records
IQVIA France technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
IQVIA France partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Partner Physicians NetworkcoreIQVIA France maintains a network of partner physicians who contribute to medical research. Healthcare professionals join the partner network to improve patient care and play a key role in developing new treatments. The network supports various medical studies including medical visit promotion, liberal prescription, autoimmune disease observatory, and anti-tumor pharmacotherapy observatory.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
IQVIA France competitors and assessment
Company assessmentDirect peers
- Parexel International: Large global CRO providing clinical trial management, biostatistics, and consulting services to pharmaceutical and biotech clients — overlapping directly with IQVIA France's clinical research services and medical studies portfolio.
- Labcorp Drug Development: Operates one of the world's largest CRO businesses (formerly Covance), offering central lab, early development, and clinical trial services. Direct competitor to IQVIA France in clinical research and lab-supported trials.
- Syneos Health: Biopharmaceutical services organization combining clinical research with commercial and medical affairs — overlapping with IQVIA France's clinical trial services and pharmaceutical commercial intelligence offerings.
- ICON plc: Global contract research organization offering clinical trial services, patient recruitment, and data analytics — directly comparable to IQVIA France's clinical research and real-world evidence offerings across pharma sponsors.
Broad incumbents
- Thermo Fisher Scientific (PPD): Acquired PPD to form a major clinical research services franchise, competing with IQVIA France across full-service CRO and decentralized trial execution, while also offering broader life sciences tools and instruments.
- Charles River Laboratories: Provides preclinical and clinical research services, manufacturing support, and research models for biopharma — comparable to IQVIA France in the clinical and translational research value chain, though more upstream.
Regional players
- Cegedim: French-headquartered healthcare data, CRM, and software vendor with deep penetration of French physicians, pharmacies, and pharma — directly comparable to IQVIA France's French data analytics and observatories business.
- Alcimed: France-based consulting and market intelligence firm serving healthcare and life sciences — adjacent to IQVIA France's market intelligence and observatory-style service offerings for French pharma and medtech clients.
Emerging players
- Medidata Solutions (Dassault Systèmes): Specialized clinical trial technology platform (Rave EDC, eCOA, decentralized trials) — directly comparable to the technology backbone behind IQVIA France's patient-facing clinical research and data capture services.
- Veeva Systems: Life sciences cloud platform with clinical, regulatory, and commercial data products — competes with IQVIA France's One View and SmartSolve-style offerings, particularly in CRM, quality, and real-world data.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
IQVIA France social profiles
Digital presenceIQVIA France financial estimates
Financial estimateRevenue estimate
Valuation estimate
IQVIA France leadership team
Management profileNumber of profiles
IQVIA France funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IQVIA France M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IQVIA France
What does IQVIA France do?
IQVIA France provides clinical research services, health data analytics, and quality management solutions to the French healthcare ecosystem. Its core offerings include patient recruitment for clinical trials (nearly 3,000 patients annually across 400 hospital centers), data visualization platforms such as One View for market performance, the SmartSolve Quality Management System for digitizing quality processes, and a portfolio of medical studies programs serving pharmaceutical companies, healthcare establishments, pharmacies, and government health agencies.
Is IQVIA France a public or private company?
IQVIA France is a public company. It is classified as public and is currently operating.
When was IQVIA France founded?
IQVIA France was founded in 2016. It employs 501 to 1,000 people.
Where is IQVIA France based?
IQVIA France is headquartered in France, France, in the Europe region.
How does IQVIA France make money?
Three revenue lines are on record. Clinical Research Services are the primary driver. The others are health Data and Analytics and medical Studies and Observatories.
Who are IQVIA France's main competitors?
Direct peers on record are Parexel International, Labcorp Drug Development, Syneos Health and ICON plc. Broad incumbents are Thermo Fisher Scientific (PPD) and Charles River Laboratories. Regional players are Cegedim and Alcimed. Emerging players are Medidata Solutions (Dassault Systèmes) and Veeva Systems.
Does IQVIA France have an API?
No public API is recorded for IQVIA France.
What industry is IQVIA France in?
IQVIA France's product category is Healthcare Data Analytics and Clinical Research Services. Its primary akta.pro industry code is HLACAOAB, eCOA/ePRO/eDiary & Patient-Facing Data Collection, with a secondary code of HLACAMAK, Lab Analytics, Utilization Management & Operational Intelligence. Its NAICS code is 54169 and its SIC code is 8000.